doxapram has been researched along with Epistaxis in 1 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
Epistaxis: Bleeding from the nose.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The mechanism of action, indications, dosing methods, and potential side effects of this agent are discussed." | 1.29 | Doxapram reversal of respiratory failure in a patient refusing assisted ventilation. ( Euerle, BD; McNamara, RM, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McNamara, RM | 1 |
| Euerle, BD | 1 |
1 other study available for doxapram and Epistaxis
| Article | Year |
|---|---|
Doxapram reversal of respiratory failure in a patient refusing assisted ventilation.
Topics: Aged; Combined Modality Therapy; Doxapram; Epistaxis; Humans; Male; Respiration, Artificial; Respira | 1994 |